Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Invitae Corp (NY: NVTA )

N/A UNCHANGED
Last Price Updated: 7:00 PM EST, Feb 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Invitae Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal
Labcorp beats Q1 sales estimates, driven by organic growth and acquisitions. Revised 2024 guidance projects higher EPS and sales growth. The acquisition of Invitae is expected to bolster Labcorp's... 
Via Benzinga
Softbank-Backed Cohesity To Acquire Veritas Data Security Unit For $3B: Report
Cohesity, a U.S.-based data security software company, is set to acquire the data protection business of Veritas, a subsidiary of Carlyle Group. 
Via Benzinga
US Stocks Gain; Uber Posts Upbeat Sales
U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.25% to 38,618.79 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
Exposures US Equities
The New York Stock Exchange Will Start Delisting Invitae (NVTA) Stock
The New York Stock Exchange has announced that it will begin the process of delisting NVTA stock based on its "abnormally low" price. 
Via InvestorPlace
Why Is Agrify (AGFY) Stock Up 57% Today?
Agrify stock is rising higher on Tuesday as investors in AGFY celebrate a new milestone for the company with a successful installation. 
Via InvestorPlace
Is Invitae Stock a Buy Now?
Invitae shares have lost more than 80% over the past year and a half. 
Via The Motley Fool
Looking Into Invitae's Recent Short Interest
Via Benzinga
(NVTA) - Analyzing Invitae's Short Interest
Via Benzinga
NVTA Stock: Invitae Plunges 78% on the Brink of Bankruptcy
NVTA stock tumbled yesterday amid a report that the firm could declare bankruptcy soon. The shares were halted for news pending. 
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
Why Is Invitae (NVTA) Stock Down 75% Today?
Although genetic testing specialist Invitae forwarded a compelling idea, the lack of business substance ultimately cratered NVTA stock. 
Via InvestorPlace
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
Invitae's financial challenges as it grapples with a $1.5 billion debt burden. Explore the company's strategic options amidst potential bankruptcy, asset shedding, and cost-cutting measures. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Invitae’s High-Stakes Financial Maneuvering: Dilution Might Not Be That Bad
Invitae Corporation faces significant challenges in addressing its liquidity concerns. The firm is exploring multiple strategies to stabilize its financial and operational footing. 
Via Talk Markets
Earnings Preview: Invitae
Via Benzinga
Is Invitae Stock a Buy Now?
Invitae shares have dropped more than 60% this year. 
Via The Motley Fool
Why Is Genetic Testing Invitae Stock Trading Higher Today?
Friday, the FDA granted de novo approval for Invitae Corporation's (NYSE: 
Via Benzinga
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
The company must pay $57 million in damages, but that's far less than expected. 
Via Investor's Business Daily
Topics Intellectual Property
Exposures Intellectual Property
US Court Prohibits NeoGenomics To Sell Type Of Diagnostic Kits To Detect Smaller Number Of Cancer Cells, Favoring Natera In Lawsuit
Shares of NeoGenomics Inc (NASDAQ: NEO) fell Thursday after the company received a preliminary injunction from a North Carolina district court, which prohibits the company from  
Via Benzinga
Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts
Invitae layoffs are a hot topic on Friday after the genetics company announced a 15% reduction of its workforce to reduce costs. 
Via InvestorPlace
Topics Workforce
Exposures Layoff
Better Growth Stock: CRISPR Therapeutics vs. Invitae
One of these stocks may be riskier than the other... 
Via The Motley Fool
Invitae (NVTA) Q3 2023 Earnings Call Transcript
NVTA earnings call for the period ending September 30, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results. 
Via Benzinga
3 Things About Invitae Every Smart Investor Knows
The last two years have been tumultuous, and there are no calm waters in sight. 
Via The Motley Fool
3 Penny Stocks That Look Like Intriguing Bets for the Long-Term
Set aside opinions on penny stocks because these three represent companies worth considering as long-term bets. 
Via InvestorPlace
Why Invitae Stock Popped Today
Invitae just received a key marketing authorization from the FDA for a first-of-its-kind cancer test. 
Via The Motley Fool
Exposures Product Safety
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations. 
Via Benzinga
Gold Down 1%; ISM Manufacturing PMI Tops Estimates
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 40 points on Monday. The Dow traded down 0.60% to 33,306.79 while the NASDAQ rose 0.29% to 13,257.86. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
Coinbase (COIN) Stock Pops 5% on Singapore License News
Coinbase has announced a new license from Singapore's Monetary Authority and that news has shares of COIN stock on the rise Monday! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Intelligent Bio Solutions (INBS) Stock Down 52% Today?
Intelligent Bio Solutions stock is falling hard on Friday after the company announced details of a share offering for INBS. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.